Valeant Pharmaceuticals's ticker is VRX and the CUSIP is 91911X104. A total of 3 filers reported holding Valeant Pharmaceuticals in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,000 | -99.9% | 360 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,731,000 | -23.4% | 360 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,481,000 | +769.9% | 360 | +500.0% | 0.00% | – |
| Q3 2017 | $860,000 | -17.1% | 60 | 0.0% | 0.00% | – |
| Q2 2017 | $1,038,000 | +56.8% | 60 | 0.0% | 0.00% | – |
| Q1 2017 | $662,000 | -24.0% | 60 | 0.0% | 0.00% | – |
| Q4 2016 | $871,000 | -40.9% | 60 | 0.0% | 0.00% | – |
| Q3 2016 | $1,473,000 | +21.9% | 60 | 0.0% | 0.00% | – |
| Q2 2016 | $1,208,000 | -42.7% | 60 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $2,110,000 | +35066.7% | 60 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $6,000 | -75.0% | 60 | -43.4% | 0.00% | -71.4% |
| Q3 2015 | $24,000 | – | 106 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 19,900 | $317,000 | 0.09% |
| CULLINAN ASSOCIATES INC | 46,000 | $732,000 | 0.06% |
| Sonora Investment Management, LLC | 360 | $5,731,000 | 0.00% |